SIREN : 887868628
DYLZANA is a French company founded 5 years ago, specialized in the sector Supermarchés. Based in BIARRITZ (64200), this company of category PME shows in 2022 a revenue of 1.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Kennzahl | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Umsatz | N/C | N/C | N/C | 1 913 456 € |
| Nettoergebnis | 4 031 € | 29 451 € | 45 262 € | 77 136 € |
| EBITDA | N/C | N/C | N/C | 113 955 € |
| Nettomarge | N/C | N/C | N/C | 4.0% |
In 2025, DYLZANA generates positive net income of 4 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2025: 77 k€ -> 4 k€.
4 031 €
The debt ratio (= Financial debt / Equity x 100) stands at 24%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
24.343%
59.739%
41.3%
In 2025, the debt ratio of DYLZANA (24.34) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2025, the financial autonomy of DYLZANA (59.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
The liquidity ratio (= Current assets / Current liabilities) stands at 229.12. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
229.115
In 2025, the liquidity ratio of DYLZANA (229.12) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 270 transactions of similar company sales in 2025, the value of DYLZANA is estimated at 25 387 € (range 10 262€ - 61 075€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 270 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare DYLZANA with other companies in the same sector:
The revenue of DYLZANA in 2022 is 1.9 M€.
Yes, DYLZANA generated a net profit of 4 k€ in 2025.
The headquarters of DYLZANA is located in BIARRITZ (64200), in the department Pyrenees-Atlantiques.
The tax return of DYLZANA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
DYLZANA operates in the sector Supermarchés (NAF code 47.11D). See the 'Sector positioning' section above to compare the company with its competitors.